You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

Filtered By:
16 Items
Cancer Type: Genitourinary, Prostate     
Intent: Palliative
Funding:
Exceptional Access Program
    abiraterone - Metastatic castrate-resistant prostate cancer, with specific criteria
ODB - General Benefit
    dexamethasone
... Show more tags
Drugs Used:
abiraterone,
dexamethasone
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Genitourinary, Prostate     
Intent: Palliative
Funding:
Exceptional Access Program
    abiraterone - Metastatic castrate-resistant prostate cancer, with specific criteria
ODB - General Benefit
    prednisone
... Show more tags
Drugs Used:
abiraterone,
prednisone
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Lymphoma - T-cell, Rare Diseases     
Intent: Palliative
Drugs Used:
alemtuzumab (Compassionate)
... Show more tags
Quick Link(s):
Regimen Monograph
Sep 2019
Cancer Type: Hematologic, Leukemia - Chronic Lymphocytic (CLL)     
Intent: Palliative
Drugs Used:
alemtuzumab (Compassionate),
riTUXimab (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Dec 2017
Cancer Type: Hematologic, Leukemia - Chronic Lymphocytic (CLL)     
Intent: Palliative
Drugs Used:
alemtuzumab (Compassionate)
... Show more tags
Quick Link(s):
Regimen Monograph
Updated
Nov 2019
Cancer Type: Hematologic, Leukemia - Chronic Lymphocytic (CLL)     
Intent: Palliative
Drugs Used:
mitoXANTRONE,
fludarabine,
cyclophosphamide,
alemtuzumab (Compassionate)
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's Low Grade     
Intent: Palliative
Drugs Used:
idelalisib (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Hematologic, Leukemia - Chronic Lymphocytic (CLL)     
Intent: Palliative
Funding:
Exceptional Access Program
    idelalisib - For the treatment of relapsed chronic lymphocytic leukemia according to specific clinical criteria
New Drug Funding Program
    Rituximab - In Combination with Idelalisib - Relapsed Chronic Lymphocytic Leukemia
... Show more tags
Drugs Used:
idelalisib,
riTUXimab
... Show more tags
Quick Link(s):
Regimen Monograph
Mar 2018
Cancer Type: Breast     
Intent: Palliative
Funding:
New Drug Funding Program
    Pamidronate - Metastatic Breast Cancer
... Show more tags
Drugs Used:
pamidronate
... Show more tags
Quick Link(s):
Regimen Monograph
Aug 2018
Cancer Type: Hematologic, Multiple Myeloma     
Intent: Palliative
Funding:
New Drug Funding Program
    Pamidronate - Plasma Cell Myeloma (with bone disease)
New Drug Funding Program
    Pamidronate - Plasma Cell Myeloma (without bone disease)
... Show more tags
Drugs Used:
pamidronate
... Show more tags
Quick Link(s):
Regimen Monograph
Feb 2017
Cancer Type: Breast, Central Nervous System, Endocrine, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Hematologic, Lung, Sarcoma, Skin, Unknown Primary     
Intent: Supportive Care, Palliative
Drugs Used:
pamidronate
... Show more tags
Quick Link(s):
Regimen Monograph
Jan 2018
Cancer Type: Hematologic, Leukemia - Chronic Myeloid (CML)     
Intent: Palliative
Funding:
Exceptional Access Program
    ponatinib - For the treatment of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia, according to specific clinical criteria
... Show more tags
Drugs Used:
ponatinib
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019